
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Triptorelin Pamoate
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Manyak, Michael, M.D. | Watson Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Details : Trelstar is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Prostatic Neoplasms.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 25, 2016
Lead Product(s) : Triptorelin Pamoate
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Manyak, Michael, M.D. | Watson Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
